Talks by the Group

P. Würtz, J.R. Raiko, C.G. Magnussen, P. Soininen, A.J. Kangas, T. Tynkkynen, R. Thomson, R. Laatikainen, M.J. Savolainen, A. Jula, J.S. Viikari, M. Kähönen, T. Lehtimäki, M. Juonala, M. Ala-Korpela, O.T. Raitakari

Comprehensive metabolic profiling improves prediction of subclinical atherosclerosis in young adults No abstract

The 79th European Atherosclerosis Society Congress

Gothenburg, Sweden, June 26-29, 2011

P. Würtz, J.R. Raiko, C.G. Magnussen, P. Soininen, A.J. Kangas, T. Tynkkynen, R. Thomson, R. Laatikainen, M.J. Savolainen, A. Jula, J.S. Viikari, M. Kähönen, T. Lehtimäki, M. Juonala, M. Ala-Korpela, O.T. Raitakari

Metabolic profiling by serum NMR spectroscopy improves prediction of subclinical atherosclerosis No abstract

17th Annual Scandinavian Atherosclerosis Conference

Copenhagen, Denmark, April 13-16, 2011

P. Würtz was acknowledged with the Young Investigator Award for best oral presentation.

P. Würtz, J.R. Raiko, C.G. Magnussen, P. Soininen, A.J. Kangas, T. Tynkkynen, R. Thomson, R. Laatikainen, M.J. Savolainen, A. Jula, J.S. Viikari, M. Kähönen, T. Lehtimäki, M. Juonala, M. Ala-Korpela, O.T. Raitakari

Metabolic profiling of subclinical atherosclerosis in young adults – risk prediction and etiological insights No abstract

Finnish Atherosclerosis Society Meeting

Tampere, Finland, March 18-19, 2011

M. Ala-Korpela invited

Serum NMR metabonomics in epidemiological studies of vascular diseases – from biomarkers to multiomics approaches. No abstract

Cardiovascular Research Seminar at the Faculty of Health Sciences, University of Copenhagen

Copenhagen, Denmark, January 13, 2011

P. Würtz, P. Soininen, A. J. Kangas, C. G. Magnussen, J. Raiko, R. Thomson, V.-P. Mäkinen, P.-H. Groop, M. J. Savolainen, J. Viikari, M. Kähönen, T. Lehtimäki, M. Juonala, O. T. Raitakari, M. Ala-Korpela

Quantitative metabolic profiling of early risk for atherosclerosis by serum NMR metabonomics

Metabolomics 2010

Amsterdam, The Netherlands, June 27-July 1, 2010

http://www.metabolomics2010.com/

P. Würtz was selected as one of the four finalists in the young scientists category.

P. Würtz

Metabolic profiling of subclinical atherosclerosis by serum NMR metabonomics. No abstract

University of Groeningen

Groeningen, The Netherlands, June 25, 2010

http://www.rug.nl/gbb/research/researchgroups/nmr/index

M. Ala-Korpela invited

Serum NMR metabonomes towards deeper metabolic phenotyping for functional genomics.

The 10th Annual International Gene Forum 2010

Tartu, Estonia, June 18-19, 2010

http://www.geneforum.ee/GF2010/index.php?inc=main

P. Würtz, P. Soininen, A. J. Kangas, V.-P. Mäkinen, P.-H. Groop, M. J. Savolainen, J. Viikari, M. Kähonen, T. Lehtimäki, M. Juonala, O. T. Raitakari, M. Ala-Korpela invited

Metabonomics for metabolic profiling of preclinical atherosclerosis.

XXXII Finnish NMR Symposium

Kuopio, Finland, June 9-11, 2010

http://2010.nmr.fi/index.shtml

M. Ala-Korpela invited

Serum NMR metabonomics in epidemiology – analytical challenges and future directions. No abstract

Central South University

Changsha, China, May 3, 2010

http://www.csu.edu.cn/english/index.htm

M. Ala-Korpela

Serum NMR metabonomics in epidemiology. No abstract

LKS Faculty of Medicine, The University of Hong Kong, Department of Orthopaedics & Traumatology, Queen Mary Hospital

Hong Kong, China, April 29, 2010

P. Würtz

Metabolic profiling of subclinical atherosclerosis by serum NMR metabonomics. No abstract

The Cardiovascular Risk in Young Finns Study Spring Seminar, Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku

Turku, Finland, April 23, 2010

M. Ala-Korpela

Serum NMR metabonomics – where we are and where we would like to go? No abstract

The Cardiovascular Risk in Young Finns Study Spring Seminar, Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku

Turku, Finland, April 23, 2010

M. Ala-Korpela

Serum NMR metabonomics in metabolic studies and profiling of obesity. No abstract

Førde Central Hospital / University of Bergen

Førde, Norway, November 25, 2009

M. Ala-Korpela invited

Serum NMR metabonomics in clinical and epidemiological studies of vascular diseases. No abstract

An expert group meeting for analytical methods for human biomonitoring

Joint Research Centre of the European Commission, Ispra, Italy, November 19-20, 2009

M. Ala-Korpela invited participation

No abstract

The International Life Sciences Institute (ILSI) Europe Workshop on Methodologies to Assess Long-term Effects of Nutrition on Brain Function

Brussels, Belgium, November 12-13, 2009

Download programme (pdf)

M. Ala-Korpela (in collaboration with Prof Olav Kvalheim, University of Bergen, Norway)

High-throughput analytical techniques and multivariate data analysis in future medicine. No abstract

A seminar day at the Central South University

Changsha, China, October 26, 2009

http://www.csu.edu.cn/english/index.htm

M. Ala-Korpela invited

Body fluid NMR. Abstract in preparation.

The 26th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB 2009)

Antalya, Turkey, October 1-3, 2009

http://www.esmrmb.org

M. Ala-Korpela & A. J. Kangas

Serum NMR metabonomics in the assessment of metabolic phenotypes and vascular risk factors. No abstract.

The Netherlands Metabolomics Centre (NMC)

Utrecht, The Netherlands, July 10, 2009

M. Ala-Korpela invited

NMR metabonomics of serum – chase for an insight into lipid metabolism, vascular complications and fat.

Metabomeeting 2009

Norwich, UK, July 5-8, 2009

http://www.thempf.org/MM09/general_info.html

M. Ala-Korpela

Serum NMR metabonomics in the assessment and follow-up of disease risk. No abstract.

Orion Pharma, Biomarker Research, Translational Sciences Nonclinical R&D

Espoo, Finland, June 15, 2009

M. Ala-Korpela invited keynote lecture

NMR metabonomics in relation to disease diagnostics, screening and prognostics: What is the clinical rationale & where is the potential importance?

The 11th Scandinavian Symposium on Chemometrics (SSC11)

Nordfjord, Norway, June 8-11, 2009

http://www.kj.uib.no/ssc11/

M. Ala-Korpela

Beyond the Friedewald formula – just extending the computations or entering into the era of serum NMR metabonomics? No abstract.

Finnish Health 2000 Study Seminar, National Institute of Health and Wellbeing

Helsinki, Finland, June 1, 2009

M. Ala-Korpela invited

Common diseases, vascular complications & NMR metabonomics - is there anything in common? No abstract.

The Annual Danish NMR Symposium, the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules, the Carlsberg Research Center

Copenhagen, Denmark, May 15, 2009

M. Ala-Korpela invited

1H NMR metabonomics of serum as a potential technology for screening and prognostics of vascular complications. No abstract.

The 15th Annual Scandinavian Atherosclerosis Conference (SSAR 2009)

Humlebæk, Denmark, April 22-25, 2009

http://ssar.dk/

M. Ala-Korpela

NMR metabonomics of serum – towards holistic high-throughput screening of vascular diseases and their complications. No abstract

Biocenter Oulu KIEPPI Spring Seminar, Faculty of Medicine, University of Oulu

Oulu, Finland, April 16, 2009

M. Ala-Korpela invited

1H NMR metabonomics of body fluids as a potential technology for screening and prognostics of vascular complications. No abstract

The Graduate School of Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences and University of Kuopio

Kuopio, Finland, April 6, 2009

P. Würtz

High-throughput metabolic phenotyping via serum NMR metabonomics - Preliminary results from the Cardiovascular Risk in Young Finns Study. No abstract.

The Cardiovascular Risk in Young Finns Study Spring Seminar, Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku

Turku, Finland, April 3, 2009

M. Ala-Korpela

High-throughput metabolic phenotyping via serum NMR metabonomics - General aspects. No abstract.

The Cardiovascular Risk in Young Finns Study Spring Seminar, Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku

Turku, Finland, April 3, 2009

M. Ala-Korpela

Serum NMR metabonomics – recent advances in high-throughput metabolic phenotyping. No abstract.

Department of Epidemiology and Public Health, Imperial College School of Medicine

London, UK, March 16, 2009

P. Soininen, A. Kangas, V.-P. Mäkinen, T. Tukiainen, P. Würtz, P. Jylänki, T. Peltola, M. Laitinen, S. Kakko, J. Niemi, L. S. Kumpula, S. M. Mäkelä, T. Tynkkynen, M. Tiainen, R. Laatikainen, O. Gröhn, C. Forsblom, M. Kivipelto, M. Hallikainen, H. Soininen, T. Pirttilä, T. Salonurmi, M. L. Hannuksela, K.-H. Herzig, P.-H. Groop, J. Viikari, O. Raitakari, M.-R. Järvelin, M. J. Savolainen & M. Ala-Korpela

Serum NMR metabonomics – high-throughput metabolic phenotyping in health and disease, and particularly in between.

The Annual Meeting of the Finnish Atherosclerosis Society

Kuopio, Finland, March 13-14, 2009

A. J. Kangas

High-throughput serum NMR metabonomics – A new technology for cost-effective holistic studies on systemic metabolism. No abstract

FinnDiane Helsinki Spring Seminar, Biomedicum Helsinki

Helsinki, Finland, March 10, 2009

http://www.finndiane.fi

M. Ala-Korpela

Computational Medicine, robots and metabolic phenotyping, NMR, MWAS & GWAS - in Oulu? No abstract

NMR Group Seminar at the Physics Department, University of Oulu

Oulu, Finland, February 13, 2009

M. Ala-Korpela invited

Clinical potential of NMR metabonomics. No abstract

Førde Central Hospital / University of Bergen

Førde, Norway, February 3-6, 2009

M. Ala-Korpela invited

NMR metabonomics as a high throughput methodology to study vascular diseases. No abstract

The 3rd Systems Radiation Biology Workshop

Rovaniemi, Finland, January 12-14, 2009

http://www.sysradbio2009.org/

M. Ala-Korpela invited

1H NMR metabonomics of serum in screening and prognostics of vascular complications. No abstract

The Silesian Centre for Heart Diseases

Zabrze, Poland, November 14, 2008

M. Ala-Korpela

1H NMR metabonomics of body fluids.

The 1st Annual Meeting of the Finnish Metabolomics Society

Helsinki, Finland, October 27, 2008

M. Ala-Korpela invited

1H NMR metabonomics of body fluids in the risk assessment of common diseases.

Department of Chemistry, Moscow State University

Moscow, Russia, October 23, 2008

M. Ala-Korpela

1H NMR metabonomics as a potential technology for disease screening and prognostics. No abstract

The European Association for the Study of Diabetes (EASD) Young Scientists Training Course (Helsinki 13.-17.10.2008)

Helsinki, Finland, October 17, 2008

V.-P. Mäkinen

Metabolic characterization of patients with type 1 diabetes using self-organizing maps (SOM). No abstract

The European Association for the Study of Diabetes (EASD) Young Scientists Training Course (Helsinki 13.-17.10.2008)

Helsinki, Finland, October 17, 2008

M. Ala-Korpela invited

1H NMR spectroscopy of serum and lipoprotein particles.

The 25th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB 2008)

Valencia, Spain, October 2-4, 2008

http://www.esmrmb.org/

M. Ala-Korpela invited

1H NMR metabonomics of serum in screening and prognostics of common diseases. No abstract

Bruker Biospin Users Meeting

Stockholm, Sweden, September 30 - October 1, 2008

M. Ala-Korpela invited

The potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool for brain related impairment and diseases.

The Brain Lipids Conference 2008

Oslo, Norway, September 8-11, 2008

http://www.bl2008.org/

V.-P. Mäkinen, P. Soininen, T. Tynkkynen, P. Jylänki, A. Kangas, C. Forsblom, R. Laatikainen, K. Kaski, P.-H. Groop, M. Ala-Korpela

Metabolic characterization of vascular complications and their progression by 1H NMR spectroscopy of serum in patients with type 1 diabetes.

The 4th Scientific Meeting of the Metabolomics Society

Boston, USA, September 2-6, 2008

http://www.metabolomicssociety.org/metabolomics2008/

M. Ala-Korpela invited

1H NMR metabonomics of serum as a potential technology for screening and prognostics of vascular complications.

The 4th Atlantic Omics Symposium

Moncton, NB, Canada, August 18-20, 2008

http://www.atlanticcancer.ca/aos/

M. Ala-Korpela invited

Biophysical and biochemical aspects of lipoprotein metabolism – towards multi-parametric assessment of disease risk by NMR metabonomics.

Invited lectures (10h summer course)

Universidad de los Andes, Bogota, Colombia, August 12-14, 2008

http://www.uniandes.edu.co/

V.-P. Mäkinen invited

Risk of premature death: studies of type 1 diabetes complications. No abstract

The 7th International Duodecim Symposium on Obesity on the Gut-Fat-Brain Axis

Hämeenlinna, Finland, June 12, 2008

M. Ala-Korpela

Opening Words & Welcome - The XXX years of Finnish NMR symposium. No abstract

The XXX Finnish NMR Symposium

Helsinki, Finland, June 11-13, 2008

http://www.nmr.fi/

V.-P. Mäkinen, C. Forsblom, L. M. Thorn, J. Wadén, D. Gordin, O. Heikkilä, K. Hietala, L. Kyllönen, J. Kytö, M. Rosengård-Bärlund, M. Saraheimo, N. Tolonen, M. Parkkonen, K. Kaski, M. Ala-Korpela, P.-H. Groop

Self-organizing map analysis of serum and urine biochemistry, vascular complications and premature death for 4297 patients with type 1 diabetes.

The 5th World Congress on Prevention of Diabetes and its Complications

Helsinki, Finland, June 1-4, 2008

V.-P. Mäkinen, C. Forsblom, L. M. Thorn, J. Wadén, D. Gordin, O. Heikkilä, K. Hietala, L. Kyllönen, J. Kytö, M. Rosengård-Bärlund, M. Saraheimo, N. Tolonen, M. Parkkonen, K. Kaski, M. Ala-Korpela, P.-H. Groop invited

Self-organizing map analysis of serum and urine biochemistry, vascular complications and premature death for 4,297 patients with type 1 diabetes.

The 5th Congress on Prevention of Diabetes and its Complications

Helsinki, Finland, June 1-4, 2008

M. Ala-Korpela, V.-P. Mäkinen, P. Jylänki, P. P. Soininen. Ingman, C. Forsblom, M. Parkkonen, K. Kaski, P.-H. Groop

Proton NMR spectroscopy of serum for lipoprotein subclass and metabolite analytics: metabolic continuum of diabetic complications and premature death in type 1 diabetes.

The European Diabetic Nephropathy Study Group (EDNSG) meeting

Hanover, Germany, May 16-17, 2008

M. Ala-Korpela invited

Lipoprotein subclass and metabolite analytics by 1H NMR metabonomics of serum. No abstract.

Unilever Research & Development

Vlaardingen, The Netherlands, May 8, 2008

M. Ala-Korpela invited

Lipoprotein and metabolite analytics by 1H NMR spectroscopy of serum – implications for metabolic phenotyping for disease risk assessment.

A PhD-course on NMR methods for metabolomics, Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen

Copenhagen, Denmark, April 2, 2008

J. Niemi, V.-P. Mäkinen, J. Heikkonen, L. Tenkanen, Y. Hiltunen, M. Hannuksela, Y. A. Kesäniemi, M. Savolainen, M. Jauhiainen, C. Forsblom, K. Kaski, P.-H. Groop, P. Kovanen and M. Ala-Korpela

A new method to estimate VLDL, IDL, LDL, HDL2, HDL3, apoA-I and apoB from the Friedewald inputs reveals the central role of IDL cholesterol and apoB in predicting vascular complications and mortality in patients with type 1 diabetes

The Annual Meeting of the Finnish Atherosclerosis Society

Helsinki, Finland, March 14-15, 2008

V.-P. Mäkinen, C. Forsblom, L. Thorn, J. Wadén, D. Gordin, O. Heikkilä, K. Hietala, L. Kyllönen, J. Kytö, M. Rosengård-Bärlund, M. Saraheimo, N. Tolonen, M. Parkkonen, K. Kaski, M. Ala-Korpela and P.-H. Groop

Self-organizing map analysis of serum and urine biochemistry, vascular complications and premature death in type 1 diabetes

The Annual Meeting of the Finnish Atherosclerosis Society

Helsinki, Finland, March 14-15, 2008

T. Tukiainen, T. Tynkkynen, V.-P. Mäkinen, J. Hokkanen, P. P. Soininen. Jylänki, A. Vehtari, O. Gröhn, M. Hallikainen, H. Soininen, M. Kivipelto, P.-H. Groop, R. Laatikainen, K. Kaski, T. Pirttilä and M. Ala-Korpela

Characterisation of metabolic phenotypes associated with cognitive decline by proton NMR metabonomics of serum – revealing the role of lipids

The Annual Meeting of the Finnish Atherosclerosis Society

Helsinki, Finland, March 14-15, 2008

M. Ala-Korpela invited

1H NMR spectroscopy of serum for lipoprotein subclass and metabolite analytics.

Experimental Nuclear Magnetic Resonance Conference, The 49th ENC

Asilomar Conference Grounds, Pacific Grove, California, USA, March 9-14, 2008

http://www.enc-conference.org/

V.-P. Mäkinen

Metabonomics of type 1 diabetes. No abstract

Department of Chemistry, University of Kuopio

Kuopio, Finland, October 9, 2007

M. Ala-Korpela invited

1H NMR metabonomics of serum in the risk assessment and diagnosis of atherothrombotic diseases – the synergy between lipoprotein lipids and small molecules

Small molecule NMR conference (SMASH 2007)

Chamonix, France, September 16-19, 2007

http://www.smashnmr.org/2007/

V.-P. Mäkinen

Interactive metabonomics in tomorrow's medicine. No abstract

Folkhälsan Research Center

Helsinki, Finland, September 6, 2007

P. Jylänki, J. Niemi, V.-P. Mäkinen, A. Salminen, L. Vanhatalo, P. P. Soininen. Ingman, K. Kaski, P.-H. Groop, A. Vehtari, M. Ala-Korpela invited

A quantitative Bayesian approach to metabonomic 1H NMR data of serum.

The Conferentia Chemometrica 2007 (CC 2007)

Budapest, Hungary, September 2-5, 2007

J. Brezmes, N. Cañellas, A. Salminen, P. Soininen, K. Kaski, X. Correig, M. Ala-Korpela

A probabilistic approach to the assessment of metabolic syndrome using 1H NMR spectroscopy of serum and Fuzzy Artmap neural networks. No abstract

The Conferentia Chemometrica 2007 (CC 2007)

Budapest, Hungary, September 2-5, 2007

M. Ala-Korpela invited

Holistic and multiparametric approaches on personalised medicine and oil product diagnostics. No abstract

Neste Oil Ltd., Research and Technology

Porvoo, Finland, August 27, 2007

M. Ala-Korpela invited

Introduction to metabonomics (and its role in health sciences) No abstract

The Metabonomics Workshop on Diabetes and Metabolic Diseases

Barcelona, Spain, July 9–10, 2007

M. Ala-Korpela invited

1H NMR spectroscopy of serum – molecular windows to study lipids and lipoproteins in health and disease. No abstract

The Metabonomics Workshop on Diabetes and Metabolic Diseases

Barcelona, Spain, July 9–10, 2007

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela

Multi-metabolite characterization of the diabetic state by 1H NMR metabonomics.

The 29th Finnish NMR Symposium

Turku, Finland, June 13–15, 2007

The talk by V.-P. Mäkinen was selected as the best oral presentation in the Young Investigator Award competition of the meeting by the scientific committee.

T. Tukiainen, J. Hokkanen, V.-P. Mäkinen, T. Tynkkynen, P. Soininen, O. Gröhn, M. Hallikainen, H. Soininen, K Kaski, R. Laatikainen, T. Pirttilä, M. Ala-Korpela

Assessment of multi-molecular associations in cognitive decline by 1H NMR metabonomics of serum.

The 29th Finnish NMR Symposium

Turku, Finland, June 13–15, 2007

M. Ala-Korpela, T. Suna, A. Salminen, J. Brezmes-Llecha, P. Soininen, T. Tynkkynen, S. M. Mäkelä, N. Lankinen, T. Peltola, L. S. Kumpula, V.-P. Mäkinen, M. J. Savolainen, X. Correig-Blanchar, R. Laatikainen, M.-R. Taskinen, M. Jauhiainen, M. L. Hannuksela, K. Kaski

Identification of lipoprotein subclass profiles characteristic to metabolic syndrome by proton NMR metabonomics of serum.

Metabolic Syndrome Satellite Symposium of the 76th Annual Congress of the European Atherosclerosis Society (EAS)

Turku, Finland, June 8-9, 2007

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela

1H NMR metabonomics of type 1 diabetes: a holistic approach to metabolic syndrome

Metabolic Syndrome Satellite Symposium of the 76th Annual Congress of the European Atherosclerosis Society (EAS)

Turku, Finland, June 8-9, 2007

M. Ala-Korpela Invited 3h lectures

Lipoprotein Particles and the Life-Long Path of Atherothrombosis – Molecular and Cellular Relationships. No abstract

Biology at the Interface – an interdisciplinary course led by Prof. Ole G. Mouritsen

MEMPHYS – Center for Biomembrane Physics, Department of Physics and Chemistry, University of Southern Denmark
Odense, Denmark
, May 11, 2007

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela

1H NMR metabonomics of type 1 diabetes: a holistic approach to metabolic syndrome.

Diabetes & Vascular Disease Research, 4, Supplement I, Abstract book, S13, 2007

The 2nd International Congress on Prediabetes and the Metabolic Syndrome

Barcelona, Spain, April 25-28, 2007

M. Ala-Korpela invited

1H NMR as a high-throughput metabonomic tool? No abstract

Department of Molecular Medicine, Biomedicum, National Public Health Institute

Helsinki, Finland, November 28, 2006

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela

Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Magnetic Resonance Materials in Physics, Biology and Medicine, Supplement 7, Book of Abstracts 334, 2006

The 23rd Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB)

Warsaw, Poland, September 21–23, 2006

Oral presentation by Ph.D. student V.-P. Mäkinen as one of the three finalists of the Young Investigator Award Competition; merited the 2 position by the scientific board.

See also:

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum Magnetic Resonance Materials in Physics, Biology and Medicine 19, 281-296, 2006

M. Ala-Korpela, V.-P. Mäkinen, A. Salminen, N. Lankinen, P. P. Soininen. Ingman, S. Mäkelä, M. Hannuksela, M. Savolainen, P.-H. Groop, K. Kaski

Metabolic changes in simulated and clinical 1H NMR data sets of serum by means of sample correlation spectroscopy and covariance analysis.

Magnetic Resonance Materials in Physics, Biology and Medicine, Supplement 7, Book of Abstracts, 104, 2006

The 23rd Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB)

Warsaw, Poland, September 21–23, 2006

M. Ala-Korpela invited

The role of metabo*omics in biomedicine 1H NMR spectroscopy in disease risk assessment and diagnostics.

The Workshop on Nanoelectronics and Photonics Systems NEPHOS

Tarragona, Spain, June 26–27, 2006

A. Vehtari, V.-P. Mäkinen, P. P. Soininen. Ingman, S. Mäkelä, M. Savolainen, M. Hannuksela, K. Kaski, M. Ala-Korpela

A novel Bayesian approach for uncovering potential spectroscopic counterparts for clinical variables in 1H NMR metabonomic applications. No abstract

J. Rousu, S. Kaski, E. Ukkonen, editors. International workshop proceedings. Helsinki University Printing House, 2006

The Workshop on Probabilistic Modeling and Machine Learning in Structural and Systems Biology (PMSB 2006)

Tuusula, Finland, 17-18 June, 2006

See video at http://videolectures.net/pmsb06_ala_anb/
Extended abstract (pdf)

See also:

A. Vehtari, V.-P. Mäkinen, P. P. Soininen. Ingman, S. M. Mäkelä, M. J. Savolainen, M. L. Hannuksela, K. Kaski, M. Ala-Korpela A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data BMC Bioinformatics 8, (Suppl 2):S8, 2007

V.-P. Mäkinen, C. Forsblom, M. Wessman, M. Parkkonen, P. P. Soininen. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela

Associating 1H NMR spectra with clinical variables: metabonomics of diabetic kidney disease.

Book of abstracts

The 28th Finnish NMR Symposium

Kuopio, Finland, June 7–9, 2006

M. Ala-Korpela, V.-P. Mäkinen, A. Salminen, T. Suna, N. Lankinen, L. Kumpula, A. Niinikoski, J. Saramäki, A. Vehtari, P. Soininen, R. Laatikainen, P. Ingman, S. Mäkelä, A. Nissinen, M. Hannuksela, M. Savolainen, P.-H. Groop, M. Jauhiainen, M.-R. Taskinen, T. Liimatainen, P. Sipola, J. Heikkonen, K. Kaski

NMR Metabonomics as a potential recipe against natural fuzziness in the borderline of health and disease.

Book of abstracts (http://www.uku.fi/nmrsymposium/boa.pdf)

The 28th Finnish NMR Symposium

Kuopio, Finland, June 7–9. 2006

V.-P. Mäkinen, C. Forsblom, M. Wessman, M. Parkkonen, P. Soininen, K. Kaski, M. Ala-Korpela, P.-H. Groop

Detection of metabonomic features from 1H NMR serum spectra: a holistic view of diabetic nephropathy.

The 41st Annual Meeting of the Scandinavian Society for the Study of Diabetes

Reykjavík, Iceland, May 26-28, 2006

V.-P. Mäkinen, C. Forsblom, M. Parkkonen, P. Soininen, K. Kaski, M. Ala-Korpela, P.-H. Groop

1H NMR metabonomics of serum – assessment of molecular indicators for diabetic nephropathy in type 1 diabetic patients.

The European Diabetic Nephropathy Study Group (EDNSG) meeting

Helsinki, Finland, May 19-20, 2006

V.-P. Mäkinen

1H NMR metabonomics of diabetic kidney disease. No abstract

Scientific meeting of the Department of Nephrology in Helsinki University Central Hospital

Espoo, Finland, May 8, 2006

V.-P. Mäkinen, C. Forsblom, M. Parkkonen, P. P. Soininen. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela

1H NMR metabonomics of serum introduction of molecular windows and assessment of indicators of metabolic complications in type 1 diabetic patients.

Atherosclerosis Club Annual Meeting

Oulu, Finland, March 17-18, 2006

M. Ala-Korpela, A. Salminen, P. Soininen, T. Suna, N. Lankinen, S. Rezzi, C. Guillou, R. Laatikainen, P. Ingman, M. Jauhiainen, M.-R. Taskinen, K. Heberger, K. Kaski

Chemometrics in 1H NMR metabonomics of plasma and lipoprotein quantification.

Abstracts of the Conferentia Chemometrica 2005 (ISBN No 963 7067 12 4)

Chemometrics VII

Hajdúszoboszló, Hungary, August 28-31, 2005

M. Ala-Korpela invited

Metabonomics by 1H NMR: Current Situation, Plasma Lipoprotein Subclass Quantification, and Potential Applications on CHD Diagnosis. No abstract

European Commission's Joint Research Centre

Ispra, Italy, May 23–25, 2005

M. Ala-Korpela invited

Applications of Modern NMR Methodology in Cardiovascular Research. No abstract

Finnish Atherosclerosis Club Meeting

Helsinki, Finland, March 11–12, 2005

More information

Mika Ala-Korpela, PhD
Professor in Computational Medicine

University of Oulu
Faculty of Medicine
Institute of Clinical Medicine
FI-90014 University of Oulu
Finland

Mobile: +358 40 1977 657
E-mail: